| # | Drug | Count |
|---|---|---|
| 0 | TRAMETINIB | 17 |
| 1 | DABRAFENIB | 16 |
| 2 | PACLITAXEL | 10 |
| 3 | FULVESTRANT | 9 |
| 4 | VEMURAFENIB | 9 |
| 5 | ZOLEDRONIC ACID | 9 |
| 6 | CARBOPLATIN | 8 |
| 7 | RITUXIMAB | 8 |
| 8 | PREDNISONE | 7 |
| 9 | GEMCITABINE HYDROCHLORIDE | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DABRAFENIB | 16 | 0.0008 |
| 1 | VEMURAFENIB | 9 | 0.0008 |
| 2 | TRAMETINIB | 17 | 0.0007 |
| 3 | CLADRIBINE | 5 | 0.0005 |
| 4 | CLOFARABINE | 1 | 0.0004 |
| 5 | VINORELBINE | 3 | 0.0004 |
| 6 | GEFITINIB | 3 | 0.0003 |
| 7 | PANITUMUMAB | 5 | 0.0003 |
| 8 | FULVESTRANT | 9 | 0.0003 |
| 9 | ZOLEDRONIC ACID | 9 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Estrogen Receptor Antagonist [EPC] | 9 | 0.0002 |
| 1 | Epidermal Growth Factor Receptor Antagonist [EPC] | 5 | 0.0001 |
| 2 | CTLA-4-directed Blocking Antibody [EPC] | 4 | 0.0001 |
| 3 | Microtubule Inhibitor [EPC] | 12 | 0.0001 |
| 4 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 6 | 0.0001 |
| 5 | Platinum-based Drug [EPC] | 14 | 0.0001 |
| 6 | Purine Antimetabolite [EPC] | 5 | 0.0001 |
| 7 | BCL-2 Inhibitor [EPC] | 3 | 0.0000 |
| 8 | Topoisomerase Inhibitor [EPC] | 3 | 0.0000 |
| 9 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 5 | 0.0000 |